<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1540">
  <stage>Registered</stage>
  <submitdate>10/08/2006</submitdate>
  <approvaldate>22/08/2006</approvaldate>
  <actrnumber>ACTRN12606000366550</actrnumber>
  <trial_identification>
    <studytitle>Determination of the Glycemic Index of Breads 
made from a Novel Wheat</studytitle>
    <scientifictitle>A randomised study determining the glycemic index of breads made from novel wheat in healthy volunteers with a normal fasting glucose (3.5-5.5 mmol/L)</scientifictitle>
    <utrn />
    <trialacronym>Novel wheat</trialacronym>
    <secondaryid>Commonwealth Scientific Industrial Research Organisation (CSIRO): HM71A</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Healthy volunteers with fasting glucose 3.5-5.5 mmol/L</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Normal metabolism and endocrine development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>All participants will be randomised to eat one meal of 100gm of bread from the new wheat flour (Yammamori) . There are 3 breads, 25%, 50% and 100% Yammamori wheat. The response to a reference carbohydrate (sugar drink) is used as a standard for comparison in these tests on 3 occasions due to the variability of the glucose response.</interventions>
    <comparator>One meal of 100gm of bread from conventional wheat. The response to a reference carbohydrate (sugar drink) is used as a standard for comparison in these tests on 3 occasions due to the variability of the glucose response.</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Glucose blood samples</outcome>
      <timepoint>At each visit at times 0, 15, 30, 45, 60, 90 &amp; 120 mins.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Insulin blood samples</outcome>
      <timepoint>At each visit at times 0, 15, 30, 45, 60, 90 &amp; 120 mins.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Normal fasting blood glucose concentration (3.5-5.5 mmol/L).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Presence of diabetes (self-reported)Sufferers of bleeding disordersKnown food allergy, hypersensitivity or intolerance to cereal foods (eg celiac sprue) Taking medications known to influence glucose tolerance (oral contraceptives are excepted) such as sulphonylureas, metformin and thiazolidinediones.Persons considered by the investigator to be unwilling, unlikely or unable to comprehend or comply with the study protocol Participation in another research study within 30 days preceding the start of this studyHistory or presence of GI, renal or hepatic disease of any cause.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Volunteers will be randomly allocated by computer generated sequence to study treatments. The treatments are coded alphabetically. Locked computer files indicate treatment allocation numerically and the treatment code is concealed from research staff.</concealment>
    <sequence>Volunteers will be initially blocked matched into 4 groups based on age, body mass index and gender, glucose level prior to randomisation by computer generated sequence</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>10/08/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>14</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Commonwealth Scientific Industrial Research Organisation, Human Nutrition</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Commonwealth Scientific Industrial Research Organisation</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>n/a</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To compare changes in blood sugar levels (glycemic index) after consumption of bread made with the new wheat flour with the response obtained following consumption of bread manufactured from conventional wheat flour.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CSIRO Human Nutrition</ethicname>
      <ethicaddress />
      <ethicapprovaldate>21/04/2006</ethicapprovaldate>
      <hrec>06/01</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Tony Bird</name>
      <address>CSIRO Human Nutrition
PO Box 10041 
Adelaide BC SA 5000</address>
      <phone>+61 8 83038902</phone>
      <fax>+61 8 8303 8899</fax>
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Anne McGuffin</name>
      <address>CSIRO Human Nutrition
PO Box 10041 
Adelaide BC SA 5000</address>
      <phone>+61 8 83038988</phone>
      <fax>+61 8 8303 8899</fax>
      <email>anne.mcguffin@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>